Atezolizumab is an antibody inhibitor, a humanized monoclonal antibody, IgG1, which targets PD-L1 and blocks the interaction of PD-L1 with PD-1. Atezolizumab has antitumor activity and promotes T-cells to attack tumor cells.
Purity:
95.10%
CAS Number:
[1380723-44-3]
Target:
Apoptosis|||Autophagy|||PD-1/PD-L1
T9902
* VAT and and shipping costs not included. Errors and price changes excepted
